Qiagen believes it has gained access to a relatively simple and inexpensive technology to bolster its offerings in the growing single-cell molecular biology market.
Both groups are making their detailed protocols available to researchers online.
Single-molecule biology and single-cell genomics are poised to enable precision medicine, writes Harvard's X. Sunney Xie in JAMA.
The firm reported revenues of $26.7 million, up 4 percent from $25.7 million in the year-ago period, but short of the Wall Street estimate of $30.7 million.
Stanford University's Karl Deisseroth and Xiaoliang Sunney Xie from Harvard University are this year's recipients of the Albany Medical Center Prize.
Speakers at the Association of Biomolecular Resource Facilities annual meeting discussed their approaches for single-cell genomic studies of tumor and immune cells.
At AGBT, Fluidigm showcased the Polaris system for integrated single-cell analysis and new applications for the C1, including high-throughput RNA-seq and protein analysis.
The deal grants Funakoshi rights to market and sell Sygnis' TruePrime single-cell genome amplification technology in Japan.
A proof-of-concept study with BGI has given WaferGen confidence to make SmartChip for single-cell genomics the firm's flagship product.
Fluidigm said that its fourth quarter revenues increased 60 percent year over year or 21 percent on an organic basis.
The Wall Street Journal looks into FamilyTreeDNA's handling of genetic genealogy searches by law enforcement.
In a point-counterpoint in the Boston Globe, researchers discuss the potential of gene editing to prevent Lyme disease, but also the pitfalls of doing so.
MIT's Technology Review reports that researchers hope to develop a CRISPR-based pain therapy.
In Science this week: atlas of malaria parasites' gene expression across their life cycles, and more.